Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
VYGR
Valuace
70
Růst
0
Zdraví
75
Cena
$ 4.24
Dnes
--0.06 (-1.57%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-58%
ROA
-44%
PE
-2
PS
6
Cena 1R
3-6
⌀ Cena
3.78
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
10-03-2026
Poslední dividenda

Profil

Voyager Therapeutics, Inc., společnost zabývající se genovou terapií, se zaměřuje na vývoj léčebných postupů a technologie platforem nové generace. Hlavní klinickou kandidátkou společnosti je VY-AADC, která je v otevřené fázi 1 klinické studie pro léčbu Parkinsonovy nemoci. Předklinické programy zahrnují VY-SOD102 pro léčbu amyotrofické laterální sklerózy; VY-HTT01 pro Huntingtonovu chorobu; VY-FXN01 pro Friedreichovu ataxii; a Tau program pro léčbu tauopatií, včetně Alzheimerovy choroby, progresivní supranukleární palsie a frontotemporální demence, stejně jako pro spinální svalovou atrofii. Společnost spolupracuje a uzavírá licenční smlouvy se společnostmi Neurocrine Biosciences, Inc., Pfizer Inc. a Novartis Pharma, A.G. na výzkum, vývoj a komercializaci produktů genové terapie spojených s adenem. Voyager Therapeutics, Inc. byla založena v roce 2013 a má sídlo v Cambridge v Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
172
Založení
2015-11-11
Adresa
75 Sidney Street
CEO
Alfred W. Sandrock Jr.,
Web
www.voyagertherapeutics.com

Podobné společnosti

AVIR
Atea Pharmaceuticals, Inc.
$ 3.29
+ $ 0.02
TRDA
Entrada Therapeutics, Inc.
$ 7.15
+ $ 0.24
HUMA
Humacyte, Inc.
$ 1.33
- $ 0.00
ARCT
Arcturus Therapeutics Holdings Inc.
$ 8.65
- $ 0.07
VNDA
Vanda Pharmaceuticals Inc.
$ 4.44
+ $ 0.04
ACHV
Achieve Life Sciences, Inc.
$ 4.42
- $ 0.17
ENTA
Enanta Pharmaceuticals, Inc.
$ 11.05
+ $ 0.06

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017201620152014
Total Revenues40.440.480.0250.040.937.4171.1104.47.610.114.217.30.0
Cost of Revenues0.00.00.04.40.00.00.00.00.00.00.00.00.0
Gross Profit40.440.480.0245.640.937.4171.1104.47.610.114.217.30.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues15.313.45.26.56.324.629.619.590.14.6
Cost of Revenues0.00.00.00.00.00.032.01.21.30.9
Gross Profit15.313.45.26.56.324.6-2.418.388.73.7
Operating Income TTM 202520242023202220212020201920182017201620152014
R&D Expenses0.00.00.092.260.873.8108.8119.764.962.342.227.78.9
Selling General & Admin Expenses0.00.00.035.831.037.235.036.333.819.713.39.95.5
Depreciation & Amortization4.14.14.74.46.25.23.82.82.11.60.60.60.2
Total Operating Expenses172.2172.2163.3128.091.7111.0143.7156.198.782.055.537.614.4
Operating Income-131.8-131.8-83.3122.0-50.8-73.627.4-51.7-91.1-71.9-41.3-20.3-14.4
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.024.425.9
Selling General & Admin Expenses0.00.00.00.00.00.00.00.010.28.3
Depreciation & Amortization1.00.91.11.01.01.11.41.21.30.9
Total Operating Expenses45.344.041.841.244.638.412.734.534.734.1
Operating Income-29.9-30.6-36.6-34.7-38.3-13.8-15.0-16.254.1-29.5
Net Income TTM 202520242023202220212020201920182017201620152014
Interest Income10.610.618.311.70.00.01.76.50.01.20.00.00.0
Interest Expense0.00.00.00.01.8-0.40.00.00.00.01.00.30.0
Other Expense12.312.319.011.74.42.49.48.12.61.21.2-9.4-2.0
IBT-119.6-119.6-64.3133.7-46.4-71.236.7-43.6-88.5-70.7-40.1-29.7-16.3
Income Tax Expense0.10.10.71.40.0-5.2-1.7-2.8-0.2-1.60.1-0.60.0
Net Income-119.7-119.7-65.0132.3-46.4-66.036.7-40.8-88.3-70.7-40.2-29.7-16.3
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income2.12.42.83.34.04.64.94.93.23.4
Interest Expense0.00.00.00.00.00.00.00.00.00.0
Other Expense2.52.83.33.74.44.84.94.93.23.4
IBT-27.4-27.8-33.4-31.0-33.9-9.0-10.1-11.357.2-26.1
Income Tax Expense0.00.10.00.00.60.00.00.00.8-0.2
Net Income-27.4-27.9-33.4-31.0-34.5-9.0-10.1-11.356.4-25.9
Per Share Data TTM 202520242023202220212020201920182017201620152014
EPS$0.00$0.00$0.00$3.08$-1.21$-1.75$0.99$-1.14$-2.75$-2.64$-1.59$-7.08$-1.11
EPS Diluted$0.00$0.00$0.00$2.97$-1.21$-1.75$0.98$-1.14$-2.75$-2.64$-1.59$-7.08$-1.11
Shares Outstanding58.758.757.743.038.437.737.135.932.126.825.34.214.7
Diluted Shares Outstanding58.758.757.744.638.437.737.335.932.126.825.34.214.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.28$-0.59
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.25$-0.59
Shares Outstanding58.758.858.758.358.057.957.757.144.043.9
Diluted Shares Outstanding58.758.858.758.358.057.957.757.145.143.9
Current Assets TTM 202420232022202120202019201820172016201520142013
Cash And Equivalents76.171.468.899.0117.4104.486.046.931.536.631.37.00.1
Short Term Investments294.9195.3162.119.915.176.7195.5108.9137.5137.8163.00.00.0
Total Cash & ST Investments371.0266.7230.9118.8132.5181.1281.5155.8169.1174.4224.37.00.1
Accounts Receivable3.34.584.50.60.78.119.00.20.12.30.40.00.0
Inventory0.00.00.00.81.76.92.25.11.91.5-29.20.00.0
Other Current Assets7.35.64.44.21.71.62.01.40.80.50.40.40.0
Total Current Assets381.6276.8319.7124.5136.7197.8304.7162.5171.8178.8195.98.40.1
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents45.143.974.871.4112.576.1143.168.865.3244.3
Short Term Investments163.8171.7161.3195.3232.8294.9256.5162.1187.728.5
Total Cash & ST Investments208.9215.6236.0266.7345.4371.0399.6230.9252.9272.7
Accounts Receivable4.02.52.14.519.73.33.584.53.33.4
Inventory0.00.00.00.00.00.00.00.00.00.0
Other Current Assets6.69.87.15.68.47.36.14.45.76.1
Total Current Assets219.6227.9245.2276.8373.4381.6409.1319.7261.9282.2
Long-Term Assets TTM 202420232022202120202019201820172016201520142013
Net Property, Plant & Equipment51.847.730.033.355.461.546.512.810.37.93.22.80.0
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments2.965.71.60.00.00.01.90.61.11.430.00.00.0
Other Long-Term Assets0.02.90.01.51.82.31.71.11.31.50.30.30.0
Total Long-Term Assets54.7116.231.634.957.263.850.114.512.710.833.63.10.0
Total Assets436.2393.1351.3159.4193.9261.6354.8177.0184.5189.6229.511.50.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment43.044.946.147.749.751.856.630.031.131.8
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments20.146.459.165.70.00.01.01.61.61.6
Other Long-Term Assets5.62.92.92.92.92.92.90.00.00.0
Total Long-Term Assets68.794.2108.0116.252.654.760.531.632.733.4
Total Assets288.3322.1353.2393.1426.0436.2469.6351.3294.7315.5
Current Liabilities TTM 202420232022202120202019201820172016201520142013
Accounts Payable2.64.01.62.60.60.64.11.01.00.60.61.61.0
Short-Term Debt6.77.23.22.85.64.23.20.00.00.00.00.02.9
Other Current Liabilities10.314.216.81.42.714.221.59.811.56.53.70.90.1
Current Liabilities40.149.864.572.651.026.876.031.715.913.823.92.54.0
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable2.11.82.64.03.22.67.61.63.31.7
Short-Term Debt7.87.67.47.27.06.75.93.23.13.0
Other Current Liabilities25.532.59.114.211.410.37.616.811.19.1
Current Liabilities35.542.040.249.844.240.172.664.561.745.4
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013
Long-Term Debt40.236.517.120.338.643.431.00.00.00.00.00.00.0
Capital Leases40.243.720.323.144.247.634.20.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.0-47.20.00.00.00.00.00.0
Total Liabilities100.893.3115.0100.398.8107.3255.2130.650.453.660.410.34.0
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt30.532.634.636.538.440.242.017.117.918.7
Capital Leases38.440.242.043.745.346.947.917.121.021.7
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities68.578.280.593.395.7100.8128.7115.0118.4116.5
Total Common Equity TTM 202420232022202120202019201820172016201520142013
Common Stock0.10.10.00.00.00.00.00.00.00.00.00.00.0
Retained Earnings-282.7-326.2-261.2-393.5-347.1-275.9-312.6-269.1-160.7-90.0-49.8-20.8-3.8
Comprehensive Income-0.5-0.40.0-0.2-0.1-0.1-0.1-0.1-0.3-0.1-0.3-22.00.0
Total Common Equity335.4299.8236.359.095.1154.399.546.4134.1135.9169.11.1-3.8
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.00.00.0
Retained Earnings-418.5-390.6-357.2-326.2-291.7-282.7-272.5-261.2-317.6-291.7
Comprehensive Income0.0-0.2-0.2-0.40.0-0.5-0.50.0-0.2-0.1
Total Common Equity219.8243.9272.7299.8330.3335.4340.9236.3176.2199.0
Other TTM 202420232022202120202019201820172016201520142013
Total Debt46.943.720.323.144.247.634.20.00.00.00.00.02.9
Book Value335.4299.8236.359.095.1154.399.546.4134.1135.9169.11.1-3.8
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value219.8243.9272.7299.8330.3335.4340.9236.3176.2199.0
Cash Flow From Operating Activities TTM 202520242023202220212020201920182017201620152014
Net Income9.0-119.7-65.0132.3-46.4-71.236.7-43.6-88.3-70.7-40.2-29.7-16.3
Depreciation & Amortization4.94.14.74.46.25.23.82.82.11.60.60.60.2
Stock-Based Compensation13.514.814.811.29.311.314.915.615.79.26.34.00.4
Change Working Capital-42.3-28.834.9-66.620.53.3-144.578.455.4-2.1-12.856.10.5
Change In Accounts Receivable0.10.381.3-83.20.57.310.5-18.50.00.00.00.00.0
Change In Accounts Payable0.91.02.4-1.02.0-0.1-3.42.6-0.30.5-0.1-0.90.6
Change In Inventories2.10.00.00.00.0-2.2-0.913.50.00.00.00.00.0
Other Non-cash Items14.3-2.8-4.7-3.4-2.1-2.5-7.7-1.01.40.72.99.83.3
Cash from Operations-19.70.00.077.9-12.5-53.5-96.748.7-15.9-61.4-42.541.3-11.9
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-27.4-27.9-33.4-31.0-34.5-9.0-10.1-11.356.4-25.9
Depreciation & Amortization1.00.91.11.01.01.11.41.21.30.9
Stock-Based Compensation3.53.54.13.73.73.44.03.63.02.9
Change Working Capital-6.9-6.9-3.1-11.816.7-21.6-26.466.1-84.92.8
Change In Accounts Receivable2.1-1.5-0.40.117.5-16.40.280.0-80.20.1
Change In Accounts Payable2.90.3-0.8-1.40.80.6-5.06.0-1.71.6
Change In Inventories0.00.00.00.00.00.00.00.00.02.1
Other Non-cash Items-0.5-0.7-2.00.3-1.5-1.9-0.5-0.885.9-1.8
Cash from Operations0.00.00.00.00.00.00.00.0-25.9-21.1
Cash Flow From Investing Activities TTM 202520242023202220212020201920182017201620152014
Capital Expenditure-4.6-2.6-3.5-3.3-2.5-1.6-12.1-7.7-4.3-4.0-5.0-1.0-3.0
Acquisitions129.90.00.0138.40.0-2.5-7.70.00.00.00.00.00.0
Investments-489.4-133.9-465.7-224.0-54.8-15.1-70.4-494.2-333.2-147.3-112.4-220.40.0
Sales of Investment230.5262.0374.385.650.082.6195.5411.3364.0147.6165.126.70.0
Other Investing Activities-223.90.00.0-138.40.02.57.70.20.00.0-0.40.0-0.3
Cash from Investing-263.50.00.0-141.6-7.365.9113.0-90.526.5-3.747.3-194.8-3.3
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.6-0.2-1.1-0.7-0.2-0.3-1.0-2.1-0.8-0.8
Acquisitions0.00.00.00.00.00.00.00.0-27.6157.5
Investments-12.5-6.6-37.9-76.9-131.0-40.8-90.0-203.9-29.0-166.5
Sales of Investment60.641.740.9118.8104.0105.455.0109.956.69.0
Other Investing Activities0.00.00.00.00.00.00.00.027.6-157.5
Cash from Investing0.00.00.00.00.00.00.00.026.8-158.3
Cash Flow From Financing Activities TTM 202520242023202220212020201920182017201620152014
Debt Repaid-4.20.00.00.00.00.00.00.00.00.00.00.00.0
Debt Issued29.443.723.4-2.8-21.1-3.413.434.20.00.00.00.0-2.9
Issuance of Common Stock114.20.00.031.10.60.00.077.60.058.00.073.00.1
Repurchase of Common Stock19.30.00.00.00.50.60.80.70.90.60.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities119.20.00.02.50.00.02.32.73.91.40.5104.822.0
Cash from Financing116.30.00.033.61.10.63.281.04.759.90.5177.722.1
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued38.4-1.8-1.8-1.7-1.6-1.6-1.027.6-0.7-0.7
Issuance of Common Stock0.00.00.00.00.00.00.00.00.50.3
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.50.3
Cash from Financing0.00.00.00.00.00.00.00.02.60.3
Cash position TTM 202520242023202220212020201920182017201620152014
Net Change in Cash-168.2-6.23.8-30.1-18.713.019.439.215.3-5.15.324.36.9
Closing Cash Balance76.168.074.270.4100.5119.2106.286.847.631.536.631.37.0
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash17.31.2-30.83.4-41.236.4-67.075.63.5-179.0
Closing Cash Balance68.045.146.877.674.2115.479.0146.068.866.9
Free Cash Flow TTM 202520242023202220212020201920182017201620152014
Free Cash Flow-24.4-135.1-18.874.7-15.0-55.1-108.840.9-20.2-65.3-47.540.3-14.9
Real Free Cash Flow-37.9-149.9-33.663.5-24.3-66.5-123.725.3-35.9-74.6-53.836.2-15.3
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-30.9-31.3-34.4-38.6-14.7-28.2-32.556.6-26.6-21.8
Real Free Cash Flow-34.4-34.7-38.5-42.2-18.4-31.7-36.653.1-29.7-24.7
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-1.9-5.9-1.4
P/S5.623.49.4
P/B13.35.2
P/FCF-1.56.8-1.5
Market cap$0.2$2.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets13.3 %7.4 %0 %
Debt to Income-32 %-23.9 %0 %
Debt to Free cash flow-25.6 %-45.7 %0 %
Interest expense percentage0 %-0.6 %0 %
Current ratio6.2 6.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-54.5 %-52.7 %0 %
ROA-41.5 %-16.1 %0 %
CapEx to Revenue6.8 %23.8 %0 %
RaD to Revenue0 %346.4 %0 %
ROEM234,732.6 280748

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin100 %93.5 %0 %
Operating margin-447.7 %-343.1 %0 %
Net margin-404.8 %-339.5 %0 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding58.8 mil 35.4 mil
Employee count0.2 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader